摘要
目的对倍他乐克治疗慢性心衰的疗效进行探讨。方法随机抽取我院在2012年1月-2014年6月治疗的90例慢性心衰患者,分为两组:对照组与观察组,对照组患者使用常规治疗方案进行治疗,而观察组患者在对照组患者治疗方案的基础上,再使用倍他乐克进行治疗,对两组患者的治疗效果进行观察以对比。结果观察组患者的治疗总有效率为95.56%,对照组为80%,存在较大差异,具备统计学意义(P<0.05)。观察组患者在血压、心功能、平均心率与对照组患者存在明显差异,具备统计学意义(P<0.05)。结论倍他乐克在慢性心衰治疗过程中的应用,不仅有效提高了患者的治疗总有效率,而且具有良好的安全性与可靠性,改善患者的临床症状与心功能,提高患者的生活质量,具有非常重要的意义,值得在临床治疗中进行大范围的推广与应用。
Objective To investigate the efficacy of metoprolol in patients with chronic heart failure.Methods A total of 90 patients with chronic heart failure who received treatment in our hospital from January 2012 to June 2014 were randomly selected for this study. These patients were divided into two groups： control group and observation group. While patients in the control group were treated with conventional therapy, patients in the observation group received metoprolol in addition to conventional therapy. The treatment outcomes in both groups were compared.Results The overall response rate in the observation group（95.56%） was significantly higher than that of the control group（80%）（P〈0.05）. Furthermore, there were significant differences in blood pressure, heart function, and mean heart rate between the observation group and control group（P〈0.05）. Conclusion Metoprolol therapy has been shown to be highly effective for patients with chronic heart failure. It not only significantly improves heart functions and quality of life in these patients, but also has high safety and reliability. Therefore, it may be widely used in the clinical treatment for chronic heart failure.
出处
《心血管病防治知识（学术版）》
2014年第10期42-44,共3页
Prevention and Treatment of Cardiovascular Disease
